Wealthspire Advisors (New York)’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,414
Closed -$240K 1052
2025
Q4
$240K Buy
5,414
+2,894
+115% +$125K ﹤0.01% 894
2025
Q3
$106K Buy
+2,520
New +$102K ﹤0.01% 991
2022
Q2
Sell
-15,397
Closed -$480K 515
2022
Q1
$480K Sell
15,397
-173
-1% -$5.1K 0.01% 279
2021
Q4
$461K Sell
15,570
-649
-4% -$19K 0.01% 333
2021
Q3
$486K Buy
16,219
+822
+5% +$28.3K 0.01% 361
2021
Q2
$559K Sell
15,397
-6,451
-30% -$240K 0.01% 214
2021
Q1
$800K Buy
+21,848
New +$804K 0.02% 301
2019
Q1
Sell
-103
Closed -$4K 569
2018
Q4
$4K Buy
+103
New +$3.57K ﹤0.01% 689

Other funds holding OHI

Wealthspire Advisors (New York)'s OHI Position: Q1 2026 in Review

Wealthspire Advisors (New York) sold out of Omega Healthcare (OHI) in Q1 2026, closing a stake of 5,414 shares — an estimated $240K sold.

Wealthspire Advisors (New York) first reported a position in OHI in Q4 2018 and held it in 8 quarters. The position peaked at $800K in Q1 2021. 744 funds tracked by Wall St. Rank hold OHI as of Q1 2026.

  • Wealthspire Advisors (New York) reported no remaining Omega Healthcare position as of Q1 2026 after selling out during the quarter.
  • Wealthspire Advisors (New York) sold 5,414 Omega Healthcare shares in Q1 2026, an estimated $240K.
  • Wealthspire Advisors (New York) first reported a position in Omega Healthcare in Q4 2018 and held it in 8 quarters.
  • Wealthspire Advisors (New York)'s Omega Healthcare position peaked at $800K in Q1 2021.
  • 744 funds tracked by Wall St. Rank held Omega Healthcare as of Q1 2026.

Based on Wealthspire Advisors (New York)'s 13F filing for Q1 2026, filed 1 May 2026.